261 related articles for article (PubMed ID: 30128748)
1. A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas.
Kamath P; Darwin E; Arora H; Nouri K
Clin Drug Investig; 2018 Oct; 38(10):883-899. PubMed ID: 30128748
[TBL] [Abstract][Full Text] [Related]
2. Basal cell carcinoma: an evidence-based treatment update.
Clark CM; Furniss M; Mackay-Wiggan JM
Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
[TBL] [Abstract][Full Text] [Related]
3. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.
Marzuka AG; Book SE
Yale J Biol Med; 2015 Jun; 88(2):167-79. PubMed ID: 26029015
[TBL] [Abstract][Full Text] [Related]
4. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
Thissen MR; Kuijpers DI; Krekels GA
J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785
[TBL] [Abstract][Full Text] [Related]
5. Current modalities and new advances in the treatment of basal cell carcinoma.
Ceilley RI; Del Rosso JQ
Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream.
Plachouri KM; Balasis S; Mallioris AF; Koumoundourou D; Georgiou S
Dermatol Ther; 2018 Sep; 31(5):e12685. PubMed ID: 30133929
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
9. [Basal cell carcinoma].
Takenouchi T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227
[TBL] [Abstract][Full Text] [Related]
10. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.
Tinelli M; Ozolins M; Bath-Hextall F; Williams HC
BMC Dermatol; 2012 Oct; 12():19. PubMed ID: 23035730
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma-treatments for the commonest skin cancer.
Berking C; Hauschild A; Kölbl O; Mast G; Gutzmer R
Dtsch Arztebl Int; 2014 May; 111(22):389-95. PubMed ID: 24980564
[TBL] [Abstract][Full Text] [Related]
12. Basal Cell Carcinoma Review.
Kim DP; Kus KJB; Ruiz E
Hematol Oncol Clin North Am; 2019 Feb; 33(1):13-24. PubMed ID: 30497670
[TBL] [Abstract][Full Text] [Related]
13. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Bahner JD; Bordeaux JS
Clin Dermatol; 2013; 31(6):792-8. PubMed ID: 24160289
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines.
Ligeralde-Bascones KI; Gulmatico-Flores Z; Lim-Bueser HG; Espinoza-Thaebtharm A; Rescober-Valencia MC; Aguila KP; Anupol EBJ; Balete SL; Barcelona MV; Castro VCS; Fineza-Dela Cruz AMB; Lansangan PP; Manrique AMB; Olitoquit KD; Ortiz ACG; Palisoc ED; Santos DGV; See MRV; Sy AJF; Sy GC; Tana MG; Tayag JJS; Teo HMT
Int J Dermatol; 2023 Jun; 62(6):812-821. PubMed ID: 36562635
[TBL] [Abstract][Full Text] [Related]
15. Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
Collier NJ; Haylett AK; Wong TH; Morton CA; Ibbotson SH; McKenna KE; Mallipeddi R; Moseley H; Seukeran D; Ward KA; Mohd Mustapa MF; Exton LS; Green AC; Rhodes LE
Br J Dermatol; 2018 Dec; 179(6):1277-1296. PubMed ID: 29889302
[TBL] [Abstract][Full Text] [Related]
16. Interventions for basal cell carcinoma of the skin.
Bath-Hextall FJ; Perkins W; Bong J; Williams HC
Cochrane Database Syst Rev; 2007 Jan; (1):CD003412. PubMed ID: 17253489
[TBL] [Abstract][Full Text] [Related]
17. [What is new in basal cell carcinoma?].
Heppt M; von Braunmühl T; Berking C
Hautarzt; 2016 Nov; 67(11):876-883. PubMed ID: 27654826
[TBL] [Abstract][Full Text] [Related]
18. A retrospective comparative study of outcome with surgical excision and repair versus nonsurgical and ablative treatments for basal cell carcinoma.
Mahajan S; Kalaivani M; Sethuraman G; Khaitan BK; Verma KK; Gupta S
Indian J Dermatol Venereol Leprol; 2021; 87(3):348-356. PubMed ID: 33666033
[TBL] [Abstract][Full Text] [Related]
19. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
Spencer JM
Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]